VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,867,361 | -10.6% | 1,592,990 | 0.0% | 0.37% | -2.1% |
| Q2 2023 | $47,964,929 | -6.9% | 1,592,990 | 0.0% | 0.38% | -13.1% |
| Q1 2023 | $51,533,227 | +12.9% | 1,592,990 | 0.0% | 0.43% | +8.2% |
| Q4 2022 | $45,655,093 | +18.4% | 1,592,990 | -0.3% | 0.40% | +13.6% |
| Q3 2022 | $38,545,000 | -11.9% | 1,598,040 | 0.0% | 0.35% | +2.3% |
| Q2 2022 | $43,755,000 | -28.6% | 1,598,040 | 0.0% | 0.34% | -6.5% |
| Q1 2022 | $61,285,000 | +33.3% | 1,598,040 | +11.3% | 0.37% | +53.8% |
| Q4 2021 | $45,984,000 | +8.7% | 1,435,640 | 0.0% | 0.24% | -5.5% |
| Q3 2021 | $42,308,000 | -13.3% | 1,435,640 | 0.0% | 0.25% | -11.5% |
| Q2 2021 | $48,783,000 | – | 1,435,640 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |